Found: 16
Select item for more details and to access through your institution.
Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22115-1
- By:
- Publication type:
- Article
Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 4, p. 337, doi. 10.1038/nbt.2157
- By:
- Publication type:
- Article
Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors.
- Published in:
- Nature Medicine, 2012, v. 18, n. 9, p. 1445, doi. 10.1038/nm0912-1445d
- By:
- Publication type:
- Article
Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-κB mediated and supports innate and adaptive anti-tumour immune priming.
- Published in:
- Molecular Cancer, 2011, v. 10, n. 1, p. 20, doi. 10.1186/1476-4598-10-20
- By:
- Publication type:
- Article
Past, Present and Future of Oncolytic Reovirus.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3219, doi. 10.3390/cancers12113219
- By:
- Publication type:
- Article
Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory Agents.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 5, p. 845, doi. 10.1038/mt.2014.253
- By:
- Publication type:
- Article
Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 10, p. 1851, doi. 10.1038/mt.2014.118
- By:
- Publication type:
- Article
The Profile of Tumor Antigens Which Can be Targeted by Immunotherapy Depends Upon the Tumor's Anatomical Site.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 11, p. 1936, doi. 10.1038/mt.2014.134
- By:
- Publication type:
- Article
The Efficacy Versus Toxicity Profile of Combination Virotherapy and TLR Immunotherapy Highlights the Danger of Administering TLR Agonists to Oncolytic Virus-treated Mice.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 2, p. 348, doi. 10.1038/mt.2012.204
- By:
- Publication type:
- Article
Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 4, p. 518, doi. 10.1093/neuonc/nov173
- By:
- Publication type:
- Article
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 422, p. 1, doi. 10.1126/scitranslmed.aam7577
- By:
- Publication type:
- Article
Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5 NULL -A20.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 5, p. 864, doi. 10.3390/v13050864
- By:
- Publication type:
- Article
Precise Scheduling of Chemotherapy Primes VEGF-producing Tumors for Successful Systemic Oncolytic Virotherapy.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 10, p. 1802, doi. 10.1038/mt.2011.147
- By:
- Publication type:
- Article
Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review.
- Published in:
- Diagnostics (2075-4418), 2015, v. 5, n. 2, p. 119, doi. 10.3390/diagnostics5020119
- By:
- Publication type:
- Article
Pre-Transplant Prediction of Acute Graft-versus-Host Disease Using the Gut Microbiome.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 24, p. 4089, doi. 10.3390/cells11244089
- By:
- Publication type:
- Article
Impact of Antibiotic Treatment on the Gut Microbiome and its Resistome in Hematopoietic Stem Cell Transplant Recipients.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 1, p. 28, doi. 10.1093/infdis/jiad033
- By:
- Publication type:
- Article